Marc André
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 7
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Laurent Daniel (4 shared papers)É. Lechevallier (4 shared papers)Christian Coulange (3 shared papers)Y. Neuzillet (1 shared paper)Dominique Rossi (2 shared papers)C. Eghazarian (1 shared paper)Marc de Fromont (2 shared papers)Eva González‐Barca (1 shared paper)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (1 paper)American Journal of Nephrology (1 paper)Hematology/Oncology Clinics of North America (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Marc André
18 papers receiving 1.1k citations
Marc André's Hit Papers
Peers
Comparison fields: 5 of 57
- Pathology and Forensic Medicine 413
- Oncology 376
- Pulmonary and Respiratory Medicine 433
- Genetics 125
- Neurology 108
Countries citing papers authored by Marc André
This map shows the geographic impact of Marc André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc André more than expected).
Fields of papers citing papers by Marc André
This network shows the impact of papers produced by Marc André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc André. The network helps show where Marc André may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc André, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study Hit paper breakdown → | 2020 | 338 |
| 2 | 2004 | 249 | |
| 3 | 2000 | 179 | |
| 4 | 1999 | 126 | |
| 5 | 1998 | 110 | |
| 6 | 2001 | 27 | |
| 7 | 2010 | 24 | |
| 8 | 2020 | 9 | |
| 9 | [CT-guided percutaneous fine needle biopsy of solid tumors of the kidney]. | 2000 | 9 |
| 10 | 2019 | 6 | |
| 11 | 2018 | 3 | |
| 12 | 2018 | 3 | |
| 13 | 2014 | 3 | |
| 14 | 2013 | 3 | |
| 15 | 2013 | 2 | |
| 16 | 2023 | 1 | |
| 17 | Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up. | 2022 | 1 |
| 18 | [Kidney tumors]. | 2004 | 1 |
| 19 | 2024 | 0 |
About Marc André
Marc André is a scholar working on Pathology and Forensic Medicine, Genetics, Pulmonary and Respiratory Medicine, Neurology and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Renal cell carcinoma treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and Synthesis and Characterization of Heterocyclic Compounds (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (413 citations), Oncology (376 citations), Pulmonary and Respiratory Medicine (433 citations), Genetics (125 citations) and Neurology (108 citations). Marc André has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Laurent Daniel, É. Lechevallier, Christian Coulange, Y. Neuzillet, Dominique Rossi, C. Eghazarian, Marc de Fromont, Eva González‐Barca, Maren Dirnberger‐Hertweck and Kami J. Maddocks. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, American Journal of Nephrology and Hematology/Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.